BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Prognosis
5 results:

  • 1. The prognosis of Radical prostatectomy, External Beam Radiotherapy plus Brachytherapy, and External Beam Radiotherapy Alone for Patients above 70 Years with Very High-Risk prostate cancer: A Population-Matched Study.
    Song P; Shu M; Yang L; Di X; Liu P; Liu Z; Zhou J; Dong Q
    Urol Int; 2022; 106(1):11-19. PubMed ID: 34515256
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification a novel set of 6 differential expressed genes in prostate cancer that can potentially predict biochemical recurrence after curative surgery.
    Li F; Ji JP; Xu Y; Liu RL
    Clin Transl Oncol; 2019 Aug; 21(8):1067-1075. PubMed ID: 30637711
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Simple risk assessment in prostate cancer patients treated with primary androgen deprivation therapy: The Korean cancer Study of the prostate risk classification.
    Choi SY; Ryu J; You D; Hong JH; Ahn H; Kim CS
    Int J Urol; 2019 Jan; 26(1):62-68. PubMed ID: 30238513
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic factors in malignant ureteric obstruction.
    Lienert A; Ing A; Mark S
    BJU Int; 2009 Oct; 104(7):938-41. PubMed ID: 19338533
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diagnosis of advanced cancer among elderly Medicare and Medicaid patients.
    Bradley CJ; Given CW; Dahman B; Luo Z; Virnig BA
    Med Care; 2007 May; 45(5):410-9. PubMed ID: 17446827
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.